Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 1, Number 3, October 2003

Review article

Role of Endothelin in Diabetic Retinopathy
pp. 243-250(8)
Authors: Lam, Hing-Chung; Lee, Jenn-Kuen; Lu, Chih-Chen; Chu, Chih-Hsun; Chuang, Ming-Ju; Wang, Mei-Chun

Favourites:
ADD

ATP-Sensitive K+ Channel Openers: Old Drugs with New Clinical Benefits for the Heart
pp. 251-258(8)
Authors: Miura, Tetsuji; Miki, Takayuki

Favourites:
ADD

Low-Molecular-Weight Heparins in Acute Coronary Syndromes
pp. 259-271(13)
Author: Korkmaz, Mehmet E.

Favourites:
ADD

Therapeutic Value of Statins for Vascular Remodeling
pp. 273-279(7)
Authors: Nagashima, Hirotaka; Kasanuki, Hiroshi

Favourites:
ADD

Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
pp. 281-299(19)
Authors: Gottmann, Uwe; van der Woude, Fokko J.; Braun, Claude

Favourites:
ADD

Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
pp. 301-313(13)
Authors: Mendizabal, Victoria E.; Adler-Graschinsky, Edda

Favourites:
ADD

Role of Mechanical Stress in Monocytes / Macrophages: Implications for Atherosclerosis
pp. 315-319(5)
Authors: Yamamoto, Keiji; Ikeda, Uichi; Shimada, Kazuyuki

Favourites:
ADD

Vasomotor Effects of Iodinated Contrast Media: Just Side Effects?
pp. 321-328(8)
Authors: Limbruno, Ugo; Caterina, Raffaele D.

Favourites:
ADD
Favourites:
ADD

Cardiovascular Diseases and the Nitric Oxide Pathway
pp. 335-346(12)
Authors: Llorens, Silvia; Nava, Eduardo

Favourites:
ADD

Large A-V Fistula: Pathophysiological Consequences and Therapeutic Perspectives
pp. 347-354(8)
Authors: Abassi, Zaid A.; Winaver, Joseph; Hoffman, Aaron

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more